E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via Β-catenin-Egr1-mediated PTEN expression

Oncogene

Volumn 30, Issue 24, 2011, Pages 2753-2766

  Lau, M T ^a   Klausen, C ^a   Leung, P C K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

catenin; E cadherin; ovarian cancer; PI3K Akt; PTEN

Indexed keywords

BETA CATENIN; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; EARLY GROWTH RESPONSE FACTOR 1; GLYCOGEN SYNTHASE KINASE 3BETA; LUCIFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; T CELL FACTOR PROTEIN; UVOMORULIN;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL DENSITY; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME REPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; MOLECULAR INTERACTION; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

BETA CATENIN; CADHERINS; CELL COUNT; CELL LINE, TUMOR; CELL PROLIFERATION; EARLY GROWTH RESPONSE PROTEIN 1; FEMALE; HUMANS; OVARIAN NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 79958789619     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.6     Document Type: Article

References (58)

1. Bast Jr RC, Hennessy B, Mills GB. (2009). The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer 9: 415-428.
2. Black PC, Brown GA, Inamoto T, Shrader M, Arora A, Siefker-Radtke AO et al. (2008). Sensitivity to epidermal growth factor receptor inhibitor requires E-cadherin expression in urothelial carcinoma cells. Clin Cancer Res 14: 1478-1486. (Pubitemid 351413932)
3. Blanco-Aparicio C, Renner O, Leal JF, Carnero A. (2007). PTEN, more than the AKT pathway. Carcinogenesis 28: 1379-1386. (Pubitemid 47243536)
4. Brugge J, Hung MC, Mills GB. (2007). A new mutational AKTivation in the PI3K pathway. Cancer Cell 12: 104-107. (Pubitemid 47199129)
5. Chalhoub N, Baker SJ. (2009). PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol 4: 127-150.
6. Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, Ben-Ze'ev A. (2003). Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol 163: 847-857. (Pubitemid 37517891)
7. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789. (Pubitemid 26004411)
8. De Santis G, Miotti S, Mazzi M, Canevari S, Tomassetti A. (2009). E-cadherin directly contributes to PI3K/AKT activation by engaging the PI3K-p85 regulatory subunit to adherens junctions of ovarian carcinoma cells. Oncogene 28: 1206-1217.
9. Eldar-Finkelman H, Argast GM, Foord O, Fischer EH, Krebs EG. (1996). Expression and characterization of glycogen synthase kinase-3 mutants and their effect on glycogen synthase activity in intact cells. Proc Natl Acad Sci USA 93: 10228-10233. (Pubitemid 26314604)
10. Fournier MV, Fata JE, Martin KJ, Yaswen P, Bissell MJ. (2009). Interaction of E-cadherin and PTEN regulates morphogenesis and growth arrest in human mammary epithelial cells. Cancer Res 69: 4545-4552.
11. Friedl P, Gilmour D. (2009). Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 10: 445-457.
12. Furnari FB, Huang HJ, Cavenee WK. (1998). The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res 58: 5002-5008. (Pubitemid 28521148)
13. Geiger B, Yehuda-Levenberg S, Bershadsky AD. (1995). Molecular interactions in the submembrane plaque of cell-cell and cell-matrix adhesions. Acta Anat (Basel) 154: 46-62. (Pubitemid 26101388)
14. Gottardi CJ, Wong E, Gumbiner BM. (2001). E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J Cell Biol 153: 1049-1060.
15. Hu Y, Li Z, Guo L, Wang L, Zhang L, Cai X et al. (2007). MAGI-2 Inhibits cell migration and proliferation via PTEN in human hepatocarcinoma cells. Arch Biochem Biophys 467: 1-9. (Pubitemid 47625295)
16. Kemler R. (1993). From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet 9: 317-321. (Pubitemid 23271755)
17. Korinek V, Barker N, Morin PJ, van WD, de WR, Kinzler KW et al. (1997). Constitutive transcriptional activation by a beta- catenin-Tcf complex in APC-/- colon carcinoma. Science 275: 1784-1787. (Pubitemid 27136714)
18. Kowalski PJ, Rubin MA, Kleer CG (2003). E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res 5: R217-R222.
19. Li DM, Sun H. (1998). PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci USA 95: 15406-15411. (Pubitemid 29018711)
20. Li Z, Wang L, Zhang W, Fu Y, Zhao H, Hu Y et al. (2007). Restoring E-cadherin-mediated cell-cell adhesion increases PTEN protein level and stability in human breast carcinoma cells. Biochem Biophys Res Commun 363: 165-170. (Pubitemid 47440154)
21. Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y et al. (2000). Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA 97: 4262-4266. (Pubitemid 30226121)
22. Maher MT, Flozak AS, Stocker AM, Chenn A, Gottardi CJ. (2009). Activity of the {beta}-catenin phosphodestruction complex at cell-cell contacts is enhanced by cadherin-based adhesion. J Cell Biol 186: 219-228.
23. Morin PJ. (1999). Beta-catenin signaling and cancer. Bioessays 21: 1021-1030.
24. Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA et al. (1998). The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc Natl Acad Sci USA 95: 13513-13518. (Pubitemid 28523003)
25. Nollet F, Berx G, van RF. (1999). The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer. Mol Cell Biol Res Commun 2: 77-85. (Pubitemid 129532310)
26. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA. (2008). Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68: 3645-3654.
27. Persad S, Troussard AA, McPhee TR, Mulholland DJ, Dedhar S. (2001). Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation. J Cell Biol 153: 1161-1174.
28. Polakis P. (1999). The oncogenic activation of beta-catenin. Curr Opin Genet Dev 9: 15-21.
29. Radu A, Neubauer V, Akagi T, Hanafusa H, Georgescu MM. (2003). PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1. Mol Cell Biol 23: 6139-6149. (Pubitemid 37013092)
30. Ramaswamy S, Nakamura N, Vazquez F, Batt DB, Perera S, Roberts TM et al. (1999). Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci USA 96: 2110-2115. (Pubitemid 29117876)
31. Reddy P, Liu L, Ren C, Lindgren P, Boman K, Shen Y et al. (2005). Formation of E-cadherin-mediated cell-cell adhesion activates AKT and mitogen activated protein kinase via phosphatidylinositol 3 kinase and ligand-independent activation of epidermal growth factor receptor in ovarian cancer cells. Mol Endocrinol 19: 2564-2578. (Pubitemid 41362669)
32. Sasaki CY, Lin H, Passaniti A. (2000). Expression of E-cadherin reduces bcl-2 expression and increases sensitivity to etoposide-induced apoptosis. Int J Cancer 86: 660-666. (Pubitemid 30249876)
33. Sawada K, Mitra AK, Radjabi AR, Bhaskar V, Kistner EO, Tretiakova M et al. (2008). Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target. Cancer Res 68: 2329-2339. (Pubitemid 351521807)
34. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R et al. (1999). The cyclin D1 gene is a target of the beta-catenin/ LEF-1 pathway. Proc Natl Acad Sci USA 96: 5522-5527. (Pubitemid 29234650)
35. Soto E, Yanagisawa M, Marlow LA, Copland JA, Perez EA, Anastasiadis PZ. (2008). p120 catenin induces opposing effects on tumor cell growth depending on E-cadherin expression. J Cell Biol 183: 737-749.
36. St Croix B, Sheehan C, Rak JW, Florenes VA, Slingerland JM, Kerbel RS. (1998). E-cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1). J Cell Biol 142: 557-571. (Pubitemid 28361560)
37. Stambolic V, MacPherson D, Sas D, Lin Y, Snow B, Jang Y et al. (2001). Regulation of PTEN transcription by p53. Mol Cell 8: 317-325. (Pubitemid 32831549)
38. Stambolic V, Woodgett JR. (1994). Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem J 303(Part 3): 701-704. (Pubitemid 24325998)
39. Stockinger A, Eger A, Wolf J, Beug H, Foisner R. (2001). E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity. J Cell Biol 154: 1185-1196. (Pubitemid 34286196)
40. Subauste MC, Nalbant P, Adamson ED, Hahn KM. (2005). Vinculin controls PTEN protein level by maintaining the interaction of the adherens junction protein beta-catenin with the scaffolding protein MAGI-2. J Biol Chem 280: 5676-5681. (Pubitemid 40280047)
41. Sun H, Lesche R, Li DM, Liliental J, Zhang H, Gao J et al. (1999). PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/ protein kinase B signaling pathway. Proc Natl Acad Sci USA 96: 6199-6204. (Pubitemid 29256643)
42. van Noort M, Clevers H. (2002). TCF transcription factors, mediators of Wnt-signaling in development and cancer. Dev Biol 244: 1-8. (Pubitemid 34271136)
43. Veatch AL, Carson LF, Ramakrishnan S. (1994). Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells. Int J Cancer 58: 393-399. (Pubitemid 24254650)
44. Virolle T, Adamson ED, Baron V, Birle D, Mercola D, Mustelin T et al. (2001). The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling. Nat Cell Biol 3: 1124-1128. (Pubitemid 33130464)
45. Weng L, Brown J, Eng C. (2001). PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways. Hum Mol Genet 10: 237-242. (Pubitemid 32123982)
46. Weng LP, Smith WM, Dahia PL, Ziebold U, Gil E, Lees JA et al. (1999). PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death. Cancer Res 59: 5808-5814.
47. Weng Z, Xin M, Pablo L, Grueneberg D, Hagel M, Bain G et al. (2002). Protection against anoikis and down-regulation of cadherin expression by a regulatable beta-catenin protein. J Biol Chem 277: 18677-18686. (Pubitemid 34952424)
48. Witta SE, Gemmill RM, Hirsch FR, Coldren CD, Hedman K, Ravdel L et al. (2006). Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines. Cancer Res 66: 944-950. (Pubitemid 43165962)
49. Woenckhaus J, Steger K, Sturm K, Munstedt K, Franke FE, Fenic I. (2007). Prognostic value of PIK3CA and phosphorylated AKT expression in ovarian cancer. Virchows Arch 450: 387-395. (Pubitemid 46466383)
50. Wong AS, Gumbiner BM. (2003). Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin. J Cell Biol 161: 1191-1203. (Pubitemid 36870179)
51. Wu C, Cipollone J, Maines-Bandiera S, Tan C, Karsan A, Auersperg N et al. (2008). The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression. Differentiation 76: 193-205. (Pubitemid 351197172)
52. Wu R, Hendrix-Lucas N, Kuick R, Zhai Y, Schwartz DR, Akyol A et al. (2007). Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways. Cancer Cell 11: 321-333. (Pubitemid 46518315)
53. Xia D, Srinivas H, Ahn YH, Sethi G, Sheng X, Yung WK et al. (2007). Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NF kappa B-dependent pathway. J Biol Chem 282: 3507-3519. (Pubitemid 47084470)
54. Yagi T, Takeichi M. (2000). Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. Genes Dev 14: 1169-1180. (Pubitemid 30327498)
55. Yanagisawa M, Anastasiadis PZ. (2006). p120 catenin is essential for mesenchymal cadherin-mediated regulation of cell motility and invasiveness. J Cell Biol 174: 1087-1096. (Pubitemid 44455195)
56. Yap AS. (1998). The morphogenetic role of cadherin cell adhesion molecules in human cancer: a thematic review. Cancer Invest 16: 252-261. (Pubitemid 28211011)
57. Yauch RL, Januario T, Eberhard DA, Cavet G, Zhu W, Fu L et al. (2005). Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients. Clin Cancer Res 11: 8686-8698. (Pubitemid 43005918)
58. Yuecheng Y, Hongmei L, Xiaoyan X. (2006). Clinical evaluation of E-cadherin expression and its regulation mechanism in epithelial ovarian cancer. Clin Exp Metastasis 23: 65-74. (Pubitemid 44576780)